What is the recommended treatment for uncomplicated urogenital Chlamydia trachomatis infection, including alternatives for pregnant patients or those allergic to doxycycline?

Treatment of Chlamydia

For uncomplicated urogenital Chlamydia trachomatis infection, treat with doxycycline 100 mg orally twice daily for 7 days as first-line therapy, or azithromycin 1 g orally as a single dose when adherence to multi-day therapy is uncertain. 1

First-Line Treatment Options

Recommended regimens for uncomplicated chlamydial infection include:

• Doxycycline 100 mg orally twice daily for 7 days 1, 2
• Azithromycin 1 g orally as a single dose 1

Both regimens demonstrate equivalent efficacy with microbial cure rates of 97-98% in clinical trials 1. However, the choice between them depends on specific clinical circumstances 1.

When to Choose Doxycycline

Doxycycline should be preferred in most cases because it:

• Has extensive safety data and longer clinical experience 1
• Costs significantly less than azithromycin 1
• May be more effective for rectal chlamydial infections (100% vs 79% efficacy) 1
• Maintains effectiveness despite concerns about adherence in real-world settings 1

When to Choose Azithromycin

Azithromycin is preferred when:

• Patient adherence to a 7-day regimen is questionable 1
• Direct observed therapy is needed 1
• The patient population has erratic healthcare-seeking behavior or unpredictable follow-up 1

Important caveat: Recent data shows 18% of patients discharged from emergency departments fail to pick up doxycycline prescriptions, and these non-adherent patients have 3.6-fold higher likelihood of returning with the same complaint 3. This supports providing azithromycin as single-dose directly observed therapy in settings where prescription pickup cannot be assured.

Alternative Regimens

If doxycycline and azithromycin cannot be used, alternative options include 1:

• Erythromycin base 500 mg orally four times daily for 7 days 1
• Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 1
• Ofloxacin 300 mg orally twice daily for 7 days 1
• Levofloxacin 500 mg orally once daily for 7 days 1

Note: Erythromycin is less efficacious than doxycycline or azithromycin, with frequent gastrointestinal side effects that reduce compliance 1. Quinolones offer no dosage advantage and are more expensive 1.

Treatment During Pregnancy

Pregnant women must not receive doxycycline or quinolones 1. The recommended regimens are 1:

First-line for pregnancy:

• Erythromycin base 500 mg orally four times daily for 7 days 1

Alternative regimens for pregnancy 1:

• Erythromycin base 250 mg orally four times daily for 14 days
• Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
• Erythromycin ethylsuccinate 400 mg orally four times daily for 14 days
• Amoxicillin 500 mg orally three times daily for 7-10 days (if erythromycin cannot be tolerated) 1, 4

Critical point: Erythromycin estolate is contraindicated in pregnancy due to hepatotoxicity 1. Amoxicillin demonstrates 98.4% cure rate with better tolerability than erythromycin (2% vs 13% discontinuation due to side effects) 4.

Test of cure is mandatory: Pregnant patients must be retested 4 weeks after treatment completion 5.

Special Populations

Adolescents

• Use adult dosing for those weighing >100 lbs 2
• For children >8 years weighing <100 lbs: 2 mg/lb divided into two doses on day 1, then 1 mg/lb daily thereafter 2
• Azithromycin safety not established for patients ≤15 years 1
• Quinolones contraindicated in patients ≤17 years 1

HIV-Infected Patients

• Treat identically to HIV-negative patients 1

Patients with Doxycycline Allergy

• Use azithromycin 1 g single dose 1
• If both contraindicated, use alternative regimens listed above 1

Follow-Up and Test of Cure

Routine test of cure is not recommended for non-pregnant patients treated with doxycycline or azithromycin unless 1:

• Symptoms persist after treatment
• Reinfection is suspected
• Therapeutic compliance is questionable

Retesting timing: If performed, wait at least 3 weeks after treatment completion to avoid false-positive results from residual dead organisms detected by NAATs 1.

Reinfection screening is critical: All women should be retested approximately 3 months after treatment, as repeat infections are common and confer elevated risk for pelvic inflammatory disease 1, 5. This is distinct from test of cure 1.

Partner Management

All sexual partners must be treated 1:

• Partners exposed within 60 days before diagnosis should be evaluated and treated 1
• For symptomatic patients, treat partners exposed within 30 days of symptom onset 1
• Treat the most recent partner even if contact occurred outside these intervals 1
• Patients must abstain from sexual intercourse for 7 days after single-dose therapy or until completion of 7-day regimen 1

Common Pitfalls to Avoid

1. Do not retest <3 weeks post-treatment: NAATs may yield false-positive results from dead organisms 1
2. Do not use quinolones in pregnancy or adolescents ≤17 years 1
3. Do not assume adherence with 7-day regimens: Consider directly observed single-dose azithromycin in high-risk populations 1, 3
4. Do not forget coinfection: Presumptively treat for chlamydia when treating gonorrhea, given high coinfection rates 1
5. Do not neglect partner treatment: Untreated partners lead to reinfection 1